Monocyte chemotactic responsiveness (MCR) in 14 patients with small cell anaplastic bronchogenic carcinoma was depressed before treatment compared with the MCR in 28 normal controls (P = 0.00004). MCR was subsequently monitored during combination chemotherapy and after 6 months the MCR had become no
β¦ LIBER β¦
What have we accomplished in the management of patients with small cell anaplastic carcinoma of the lung?
β Scribed by William T. Sause
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 118 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Normalization of defective monocyte chem
β
H. Nielsen; J. Bennedsen; P. Dombernowsky
π
Article
π
1982
π
Springer-Verlag
π
English
β 327 KB
Peritoneoscopy in the staging of 190 pat
β
Per Dombernowsky; Fred Hirsch; Heine H. Hansen; Bo Hainau
π
Article
π
1978
π
John Wiley and Sons
π
English
β 433 KB
π 3 views
Cell kinetic studies in patients with sm
β
Franco M. Muggia; Susan K. Krezoski; Heine H. Hansen
π
Article
π
1974
π
John Wiley and Sons
π
English
β 697 KB
Bone marrow involvement in small cell an
β
Fred R. Hirsch; Heine H. Hansen
π
Article
π
1980
π
John Wiley and Sons
π
English
β 444 KB
π 2 views
Detection of bone marrow relapse in pati
β
Paul E. G. Kristjansen; Kell Γsterlind; Mogens Hansen
π
Article
π
1986
π
John Wiley and Sons
π
English
β 403 KB
π 3 views
Vincristine, adriamycin, cyclophosphamid
β
F. E. Eyben; Γ
. Arwidi; C. Hellekant; K. Jonsson; S. Γ
. Lindahl; W. Mattsson; L.
π
Article
π
1982
π
Springer
π
English
β 299 KB
Twelve patients with small-cell anaplastic carcinoma of the lung were treated with vincristine 1 mg/m2 i.v. day 1, adriamycin 50 mg/M2 i.v. day 1, cyclophosphamide 1,000 mg/m2 i.v. day 1, and etoposide 80 mg/m2 i.v. day 2, 4, 6 given on an outpatient basis and repeated at 3-week intervals. As consol